111 related articles for article (PubMed ID: 8680680)
1. The effect of an anti-CD3 monoclonal antibody on bleomycin-induced lymphokine production and lung injury.
Sharma SK; MacLean JA; Pinto C; Kradin RL
Am J Respir Crit Care Med; 1996 Jul; 154(1):193-200. PubMed ID: 8680680
[TBL] [Abstract][Full Text] [Related]
2. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
Kelso A
J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
[TBL] [Abstract][Full Text] [Related]
3. Preventive effect of hochu-ekki-to, a Japanese herbal medicine, on bleomycin-induced lung injury in mice.
Tajima S; Bando M; Yamasawa H; Ohno S; Moriyama H; Terada M; Takada T; Suzuki E; Gejyo F; Sugiyama Y
Respirology; 2007 Nov; 12(6):814-22. PubMed ID: 17986108
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of lymphokine production in mitogen-stimulated murine spleen cells.
Sander B; Cardell S; Möller G; Möller E
Eur J Immunol; 1991 Aug; 21(8):1887-92. PubMed ID: 1831130
[TBL] [Abstract][Full Text] [Related]
5. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
Sakamoto H; Zhao LH; Jain F; Kradin R
Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD3-induced anergy in cloned human Th0, Th1, and Th2 cells.
Nguyen DD; Beck L; Spiegelberg HL
Cell Immunol; 1995 Oct; 165(1):153-7. PubMed ID: 7671320
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.
Wissing KM; Desalle F; Abramowicz D; Willems F; Leo O; Goldman M; Alegre ML
Transplantation; 1999 Sep; 68(5):677-84. PubMed ID: 10507488
[TBL] [Abstract][Full Text] [Related]
9. Central role for TCR/CD3 ligation in the differentiation of CD4+ T cells toward A Th1 or Th2 functional phenotype.
Röcken M; Müller KM; Saurat JH; Müller I; Louis JA; Cerottini JC; Hauser C
J Immunol; 1992 Jan; 148(1):47-54. PubMed ID: 1345789
[TBL] [Abstract][Full Text] [Related]
10. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
11. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
12. Developmental regulation of IL-4, IL-2, and IFN-gamma production by murine peripheral T lymphocytes.
Adkins B; Ghanei A; Hamilton K
J Immunol; 1993 Dec; 151(12):6617-26. PubMed ID: 7903095
[TBL] [Abstract][Full Text] [Related]
13. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; Rüde E; Schmitt E
J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903
[TBL] [Abstract][Full Text] [Related]
14. Fas cross-linking mimics the inhibitory effect of anti-CD3 on IL-3-induced histamine and cytokine production by murine myeloid spleen cell precursors.
Ben Amor A; Schneider E; Arnould A; Machavoine F; Dy M
Exp Hematol; 1998 Aug; 26(9):903-9. PubMed ID: 9694512
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells.
Germann T; Gately MK; Schoenhaut DS; Lohoff M; Mattner F; Fischer S; Jin SC; Schmitt E; Rüde E
Eur J Immunol; 1993 Aug; 23(8):1762-70. PubMed ID: 8102100
[TBL] [Abstract][Full Text] [Related]
16. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway.
Ferran C; Dy M; Sheehan K; Schreiber R; Grau G; Bluestone J; Bach JF; Chatenoud L
Eur J Immunol; 1991 Oct; 21(10):2349-53. PubMed ID: 1833202
[TBL] [Abstract][Full Text] [Related]
17. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.
van Lier RA; Brouwer M; Rebel VI; van Noesel CJ; Aarden LA
Immunology; 1989 Sep; 68(1):45-50. PubMed ID: 2530156
[TBL] [Abstract][Full Text] [Related]
18. Emergence of Th2-like cells after anti-CD3 monoclonal antibody administration in mice.
Wissing M; Alegre ML; Abramowicz D; Willems F; Donckier V; Vanderhaeghen ML; Leo O; Goldman M
Transplant Proc; 1995 Feb; 27(1):378-9. PubMed ID: 7879027
[No Abstract] [Full Text] [Related]
19. Manipulation of the superantigen-induced lymphokine response. Selective induction of interleukin-10 or interferon-gamma synthesis in small resting CD4+ T cells.
Cardell S; Höidén I; Möller G
Eur J Immunol; 1993 Feb; 23(2):523-9. PubMed ID: 7679648
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
